The CEO of the company, Villaume Kal, has decided to further his career elsewhere, in full alignment and with the thanks of the Supervisory Board.
The Chair, Mark Tijssen: “The Board appreciates Villaume’s continued contribution to the accelerated growth of the company worldwide”.
CEO, Villaume Kal: “It was a privilege to work with so many passionate and talented colleagues, who are all focused on the mission to advance our genetic progress globally”.
Mr. Olijslagers CTO and Mr. Van Sundert CFO, will temporarily jointly assume the CEO duties.
